Markets · 1 sources covering this

US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump

US stock futures rose in early trading Friday, putting the Nasdaq 100 on track to end a five-day losing streak as yields hold steady and Bitcoin soars.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump
US stock futures rose in early trading Friday, putting the Nasdaq 100 on track to end a five-day losing streak as yields hold steady and Bitcoin soars.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/059b6d9b24b4972c057005a3b2d37983c5376255"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump"></iframe>

US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump

How 1 sources are covering this

US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump

More from Markets

German Manufacturing Boost, French Businesses Hit By Heatwave | The Pulse 8/21/2026

MLB Labor Dispute Drives Record Short Interest in Braves Stock

Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped

India’s Nuclear Opening Comes With a High Security Bar

Reader

Trust & legal

Across the network

How 1 sources are covering this

US Stock Futures Gain as Nasdaq 100 Looks to Snap Five-Day Slump

More from Markets

German Manufacturing Boost, French Businesses Hit By Heatwave | The Pulse 8/21/2026

MLB Labor Dispute Drives Record Short Interest in Braves Stock

Moderna&#x2019;s personalized mRNA shot could reshape the fight against skin cancer &#x2014; but it may also be overhyped

India’s Nuclear Opening Comes With a High Security Bar

Reader

Trust & legal

Across the network

Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped